首页> 外文期刊>Turkish journal of biology >Cancer stem cells: emerging actors in both basic and clinical cancer research
【24h】

Cancer stem cells: emerging actors in both basic and clinical cancer research

机译:癌症干细胞:基础和临床癌症研究中的新兴参与者

获取原文
获取原文并翻译 | 示例
           

摘要

Cancer stem cells (CSCs) are a small subset of cancer cells within a tumor that are responsible for tumorigenesis and contribute to drug resistance. The CSC displays an anchorage-independent survival, active DNA-repair capacity, and relative quiescence and is capable of self-renewing and maintaining tumor growth and heterogeneity. At the molecular level, there are several signaling pathways (e. g., Wnt/beta-catenin, Notch, and Hedgehog) to control CSC properties and alteration of these pathways has been recognized as an essential step for CSC transformation. Emerging evidence suggests that CSCs are clinically relevant. These cells are resistant to conventional chemotherapy and radiation treatment. Therefore, CSCs are thought to be the most important targets for anticancer therapy. In this review, we describe the characteristics of CSCs and how to isolate them based on some of their properties, as well as their importance in oncology.
机译:癌症干细胞(CSC)是肿瘤中一小部分癌细胞,它们负责肿瘤发生并有助于耐药性。 CSC显示出不依赖于锚定的存活,活跃的DNA修复能力和相对的静止性,并且能够自我更新并维持肿瘤的生长和异质性。在分子水平上,存在几种控制CSC特性的信号传导途径(例如,Wnt /β-连环蛋白,Notch和Hedgehog),并且这些途径的改变已被认为是CSC转化的必要步骤。新兴证据表明,CSC在临床上具有相关性。这些细胞对常规化学疗法和放射治疗具有抗性。因此,CSC被认为是抗癌治疗的最重要目标。在这篇综述中,我们描述了CSC的特征以及如何基于它们的某些特性以及它们在肿瘤学中的重要性来隔离它们。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号